Showing results (261-270 of 280) with videos related to

Sort By:
Pageof 28
European Heart Journal|March 1, 2008
Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT studyEldrin F Lewis, Eric J Velazquez, Scott D Solomon, et al.
Heart (British Cardiac Society)|April 1, 2016
Effect of prior clopidogrel use on outcomes in medically managed acute coronary syndrome patientsChee Tang Chin, William E Boden, Matthew T Roe, et al.
American Heart Journal|June 2, 2020
In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular eventsHarvey D White, Ralph A H Stewart, Anthony J Dalby, et al.
Science Advances|February 27, 2021
The use of nanovibration to discover specific and potent bioactive metabolites that stimulate osteogenic differentiation in mesenchymal stem cellsTom Hodgkinson, P Monica Tsimbouri, Virginia Llopis-Hernandez, et al.
Biomaterials|November 23, 2021
Materials-driven fibronectin assembly on nanoscale topography enhances mesenchymal stem cell adhesion, protecting cells from bacterial virulence factors and preventing biofilm formationLaila A Damiati, Monica P Tsimbouri, Virginia-Llopis Hernandez, et al.
Cell Reports. Medicine|September 9, 2020
Microbiota Supplementation with Bifidobacterium and Lactobacillus Modifies the Preterm Infant Gut Microbiota and Metabolome: An Observational StudyCristina Alcon-Giner, Matthew J Dalby, Shabhonam Caim, et al.
Circulation|September 1, 2016
Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54)Marc P Bonaca, Shinya Goto, Deepak L Bhatt, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 30, 2019
Nanoscale Coatings for Ultralow Dose BMP-2-Driven Regeneration of Critical-Sized Bone DefectsZhe A Cheng, Andres Alba-Perez, Cristina Gonzalez-Garcia, et al.
The American Journal of Medicine|March 17, 2022
Effect of Alirocumab on Incidence of Atrial Fibrillation After Acute Coronary Syndromes: Insights from the ODYSSEY OUTCOMES TrialRenato D Lopes, Patrícia O Guimarães, Gregory G Schwartz, et al.
Journal of the American College of Cardiology|May 14, 2021
Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI TrialsLawrence A Leiter, Deepak L Bhatt, Darren K McGuire, et al.
Pageof 28